Summary

Revenue : 000,000 M USD
Finance : 000,000 M USD
Earning Cap : 000,000 M USD
Invest : 000,000 M USD
R & D : 0000 People
Growth : 00% AGR

DIGDAL CAP

Overview

General Introduction Gansu Longshen Rongfa Pharmaceutical Co., Ltd. is a listed company on the Growth Enterprise Market (GEM) controlled by Gansu Pharmaceutical Investment Group Co., Ltd. (stock abbreviation: Longshen Rongfa; stock code: 300534). The company is located at 138 Jinke Road, Dingyuan Town, Dinglian Park, Lanzhou High tech Zone, Gansu Province, with a registered capital of 303.345 million yuan. It has two wholly-owned subsidiaries (Gansu Shenkang Pharmaceutical Technology Co., Ltd. and Gansu New Silk Road Industrial Investment Co., Ltd.) Two holding companies (Gansu Pu'an Pharmaceutical Co., Ltd. and Gansu Pharmaceutical Group Sanyuan Pharmaceutical Co., Ltd.), with more than 600 employees, are mainly engaged in the R&D, production and sales of traditional Chinese patent medicines and simple preparations and health food, and involved in the cultivation, acquisition, processing, sales and pharmaceutical commercial circulation of Chinese medicinal materials. The company is a national high-tech enterprise and one of the first batch of strategic emerging industry backbone enterprises in Gansu Province. It has established multiple provincial-level technology platforms, including the Gansu Provincial Enterprise Technology Center, the Gansu Provincial Traditional Chinese Medicine New Drug Formulation Research Engineering Laboratory, and the Gansu Provincial Key Laboratory of Traditional Chinese Medicine Solid Dispersion Preparations. It has won the Gansu Provincial Enterprise Quality Credit Grade AA Enterprise and the Gansu Provincial Science and Technology Progress Second Prize More than 20 honors and titles, including the May Day Labor Award in Gansu Province. The company's "Longshen" and "Puankang" trademarks have successively been recognized as "Gansu Famous Trademark" and "China Famous Trademark". The company currently has 5 dosage forms, including drop pills, mixtures, tablets, hard capsules, and films, with a total of 25 product varieties. There are 24 varieties of its Chinese drug registration number (16 held by Longshen Rongfa and 8 held by Pu'an Pharmaceutical), and 1 variety of health food (Huangqi Danggui Capsules). Three are listed in the National Essential Drug Catalogue, four are listed in OTC Class A, and five are listed in the National Essential Medical Insurance, Work Injury Insurance, and Maternity Insurance Drug Catalogue. The main products include Yuanhu Zhitong Dropping Pills, Xuanfei Zhisou Mixture, Qiwei Wenyang Capsules, Maxing Zhike Capsules, Suanzaoren Oil Dropping Pills, Xiaoshuan Tongluo Tablets, Xiaoyan Lidan Tablets, Compound Danshen Tablets, Snag Pharmaceutical Film, Huangqi Danggui Capsules, etc. Among them, Yuanhu Zhitong Dropping Pills, Xuanfei Zhisou Mixture, Snag Pharmaceutical Film, Suanzaoren Oil Dropping Pills, and Qiwei Wenyang Capsules are five exclusive varieties in China. The company's main product, Yuanhu Zhitong Dropping Pill, is a pure traditional Chinese medicine general practice medication without addiction. It is widely used in clinical practice and has significant therapeutic effects on treating menstrual abdominal pain, stomach pain, flank pain, and headache. It has been continuously listed in the "National Basic Medication Catalogue" and selected as a national major variety of traditional Chinese medicine and a major variety of Longyao. With its core, "Research on the Secondary Development of Yuanhu Zhitong Dropping Pill" is the first batch of monographs on the secondary development and research of major Chinese medicine varieties in China, It provides important theoretical and experimental basis for product application and clinical practice, and the product market has broad prospects; The main product, Xuanfei Zhisou Mixture, is a national level six class new drug, a second class protected variety of traditional Chinese medicine, and a national medical insurance variety. It has won awards such as the third prize for scientific and technological progress in Gansu Province, the first prize for development in Gansu Pharmaceutical Association, and the new product and new technology award in Gansu Province. It has also been included in the "2018 Chinese Medicine Large Variety Science and Technology Competitiveness Ranking", In March 2022, it was included in the "Shanghai novel coronavirus Infection Expert Consensus on Traditional Chinese Medicine Diagnosis and Treatment" (Spring 2022), and in April 2022, it was included in the "Gansu novel coronavirus Pneumonia TCM Prevention and Treatment Plan (Fourth Edition)". The annual sales of single varieties of Yuanhu Zhitong Dropping Pills and Xuanfei Zhisou Mixture both exceed 300 million yuan. In the future development, Longshen Rongfa will closely grasp the strong support provided by the state and Gansu Province for the development of the traditional Chinese medicine industry, accelerate the construction of the national comprehensive experimental zone for the development of the traditional Chinese medicine industry, comprehensively enhance the overall strength of the industry, focus on cultivating new growth poles for economic transformation and development in the province, and strive to create an innovation platform for industry chain extension, process technology upgrading, and resource integration, towards the goal of modernization and internationalization of traditional Chinese medicine, Efforts will be made to build Longshen Rongfa into a leading enterprise in Longyao, integrating standardized traditional Chinese medicine cultivation, deep processing of traditional Chinese medicine, new drug research and development, modern traditional Chinese medicine production, and pharmaceutical trade logistics, with a complete industrial chain.
Headquarter Lanzhou
Establish Date 6/3/2002
Listed Code 300534.SZ
Listed Date 9/13/2016
Chairman Song Minping.
CEO Qian Shuangxi.
Website www.lsrfzy.com

Buy Premium Now

$15/month billed now

View the full stack of insights immediately

Or 7 Days Free Charge for Trial

See feature available in the Trial and Premium

See our Solution and Servicetrial.solutionservice.trial

See our Uniquness and Value deliveringtrial.solutionservice.trial